{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:16:34Z","timestamp":1763727394217,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI60579"],"award-info":[{"award-number":["U01AI60579"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1051297"],"award-info":[{"award-number":["GNT1051297"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC Centre of Research Excellence PRISM2","doi-asserted-by":"publisher","award":["GNT1058804"],"award-info":[{"award-number":["GNT1058804"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Murdoch Children\u2019s Research Institute of Melbourne, Australia"},{"DOI":"10.13039\/501100000925","name":"NHMRC Principal Research","doi-asserted-by":"publisher","award":["GNT 1117140"],"award-info":[{"award-number":["GNT 1117140"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.091","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T09:09:58Z","timestamp":1541236198000},"page":"7618-7624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8"],"prefix":"10.1016","volume":"36","author":[{"given":"Patricia Therese","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre R.","family":"Smeesters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Batzloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Geard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"McVernon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.10.091_b0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.091_b0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/INF.0b013e318281da11","article-title":"Progress toward a global group A streptococcal vaccine","volume":"32","author":"Steer","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.091_b0015","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/374800","article-title":"Protection against group A Streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection","volume":"187","author":"Batzloff","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.091_b0020","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1080\/21645515.2016.1222999","article-title":"Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate","volume":"12","author":"Batzloff","year":"2016","journal-title":"Hum Vacc Immunotherapeut"},{"key":"10.1016\/j.vaccine.2018.10.091_b0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4161\/hv.23224","article-title":"Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197","volume":"9","author":"Caro-Aguilar","year":"2013","journal-title":"Hum Vacc Immunotherapeut"},{"key":"10.1016\/j.vaccine.2018.10.091_b0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/CVI.00291-08","article-title":"Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not","volume":"16","author":"Steer","year":"2009","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2018.10.091_b0035","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1371\/journal.pntd.0000467","article-title":"High burden of impetigo and scabies in a tropical country","volume":"3","author":"Steer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.10.091_b0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/INF.0b013e318194b2af","article-title":"Prospective surveillance of streptococcal sore throat in a tropical country","volume":"28","author":"Steer","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.091_b0045","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/jiu260","article-title":"A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development","volume":"210","author":"Sanderson-Smith","year":"2014","journal-title":"J Infect Dis"},{"year":"2015","series-title":"ELISA Methods and Protocols","author":"Hnasko","key":"10.1016\/j.vaccine.2018.10.091_b0050"},{"key":"10.1016\/j.vaccine.2018.10.091_b0055","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/cid\/cix599","article-title":"Immune cross-opsonization within emm clusters following group A Streptococcus skin infection: broadening the scope of type-specific immunity","volume":"65","author":"Frost","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.091_b0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/sim.4780100502","article-title":"Constructing time-specific reference ranges","volume":"10","author":"Royston","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2018.10.091_b0065","first-page":"24","article-title":"Age-specific reference intervals (\u201cnormal ranges\u201d)","volume":"34","author":"Wright","year":"1996","journal-title":"STATA Tech Bull"},{"key":"10.1016\/j.vaccine.2018.10.091_b0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/intimm\/11.4.569","article-title":"Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities","volume":"11","author":"Brandt","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2018.10.091_b0075","doi-asserted-by":"crossref","first-page":"e1006122","DOI":"10.1371\/journal.ppat.1006122","article-title":"Streptococcal immunity is constrained by lack of immunological memory following a single episode of pyoderma","volume":"12","author":"Pandey","year":"2016","journal-title":"PLoS Pathog"},{"year":"2010","series-title":"Immunogenicity and protective efficacy of an anti-Streptococcus pyogenes vaccine candidate in multiple animal species","author":"Sheel","key":"10.1016\/j.vaccine.2018.10.091_b0080"},{"key":"10.1016\/j.vaccine.2018.10.091_b0085","article-title":"Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy","volume":"3","author":"Pandey","year":"2018","journal-title":"npj Vacc"},{"key":"10.1016\/j.vaccine.2018.10.091_b0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jpids\/piw070","article-title":"Prospective longitudinal analysis of immune responses in pediatric subjects after pharyngeal acquisition of Group A Streptococci","volume":"6","author":"Hysmith","year":"2017","journal-title":"J Pediat Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2018.10.091_b0095","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.1202333","article-title":"Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help","volume":"190","author":"Pandey","year":"2013","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:55Z","timestamp":1759400935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18314889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":19,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18314889"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.091","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of group A Streptococcus immune responses in an endemic setting, with a particular focus on J8","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}